Papers
1
Total Citations
23
H-Index
1
About
John W. Davis is a leading urologic oncologist whose research centers on improving the precision of prostate cancer diagnosis and treatment. His work addresses a critical clinical challenge: the frequent discordance between prostate biopsy Gleason scores and the final pathology found at radical prostatectomy. Davis’s seminal 2019 study, cited 23 times, systematically analyzed this “regression to the mean” phenomenon, identifying routine clinical features that predict upgrading or downgrading of Gleason scores. By correlating these discrepancies with biochemical relapse rates, he provided actionable insights that refine risk stratification and guide treatment decisions for men with clinically localized prostate cancer. This work directly impacts how clinicians interpret biopsy results and counsel patients on management options, from active surveillance to definitive therapy. Davis’s contributions help bridge the gap between initial diagnostic information and true disease biology, ultimately improving prognostic accuracy and reducing overtreatment. His research continues to shape evidence-based recommendations for prostate cancer care, making him a respected voice in the field of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1